The Nup107-160 Complex: Potential Drug Target and Biomarker for Diseases
The Nup107-160 Complex: Potential Drug Target and Biomarker for Diseases
The Nup107-160 complex is a protein that is expressed in various tissues of the body, including the brain, pancreas, and gastrointestinal tract. It is composed of two subunits, Nup107 and Nup120, which are involved in various cellular processes. 160 complex has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and gastrointestinal disorders.
The Nup107-160 complex is involved in several cellular processes that are essential for cell survival and function. One of the main functions of the Nup107-160 complex is to regulate the actinin cytoskeleton, which is a structure that provides support and stability to the cell's cytoplasm. The Nup107-160 complex helps to maintain the cytoskeleton in a proper state, which is critical for cell movement, division, and other cellular processes.
Another function of the Nup107-160 complex is to regulate the distribution of intracellular signaling molecules, including neurotransmitters and hormones. The complex helps to ensure that these molecules are properly targeted to their respective cells and that they do not diffuse into other parts of the cell , which can cause unnecessary signaling and interference with the cell's normal function.
The Nup107-160 complex is also involved in the regulation of cell adhesion, which is the process by which cells stick together to form tissues and organs. The complex helps to ensure that cells stick together in the correct location and that they do not detach or migrate away from their adhesion sites, which are critical for the development and maintenance of tissues.
In addition to its role in cellular processes, the Nup107-160 complex has also been shown to play a role in the development and progression of various diseases. For example, the complex has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Studies have shown that the Nup107-160 complex is expressed in the brains of individuals with these conditions and that it is involved in the regulation of neurotransmitter signaling and the formation of neuroamyloid plaques, which are thought to contribute to the development of these diseases.
The Nup107-160 complex has also been shown to be involved in the development and progression of gastrointestinal disorders, such as inflammatory bowel disease and colorectal cancer. Studies have shown that the complex is expressed in the gut tissues of individuals with these conditions and that it is involved in the regulation of cellular processes that are critical for the development and progression of these diseases.
In conclusion, the Nup107-160 complex is a protein that is involved in various cellular processes that are essential for cell survival and function. It has been identified as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and gastrointestinal disorders. Further research is needed to fully understand the role of the Nup107-160 complex in these diseases and to develop effective treatments.
Protein Name: Nup107-160 Complex
The "Nup107-160 complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Nup107-160 complex comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NUP133 | NUP153 | NUP155 | NUP160 | NUP188 | NUP205 | NUP210 | NUP210L | NUP210P1 | NUP210P2 | NUP214 | NUP35 | NUP37 | NUP42 | NUP43 | NUP50 | NUP50-DT | NUP54 | NUP58 | NUP62 | NUP62CL | NUP85 | NUP88 | NUP93 | NUP98 | NUPR1 | NUPR2 | NUS1 | NUS1P1 | NUS1P3 | NUSAP1 | NUTF2 | NUTF2P4 | NUTM1 | NUTM2A | NUTM2A-AS1 | NUTM2B | NUTM2B-AS1 | NUTM2D | NUTM2E | NUTM2F | NUTM2G | NVL | NWD1 | NWD2 | NXF1 | NXF2 | NXF3 | NXF4 | NXF5 | NXN | NXNL1 | NXNL2 | NXPE1 | NXPE2 | NXPE3 | NXPE4 | NXPH1 | NXPH2 | NXPH3 | NXPH4 | NXT1 | NXT2 | NXTAR | NYAP1 | NYAP2 | NYNRIN | NYX | OACYLP | OAF | OARD1 | OAS1 | OAS2 | OAS3 | OASL | OAT | OATP1 | OAZ1 | OAZ2 | OAZ3 | OBI1 | OBI1-AS1 | OBP2A | OBP2B | OBSCN | OBSCN-AS1 | OBSL1 | OC90 | OCA2 | OCEL1 | OCIAD1 | OCIAD2 | OCLM | OCLN | OCLNP1 | OCM | OCM2 | OCRL | OCSTAMP | ODAD1
